Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedPublications section updated to clarify that entries are automatically filled from PubMed and may not be about the study, and the revision tag was updated to v3.3.2; the deletion note reiterates PubMed as the source with revision tag v3.2.0.SummaryDifference0.1%

- Check25 days agoChange DetectedRemoved the government funding lapse notice from the page, including references to NIH Clinical Center operating status and opm.gov updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedThe new screenshot appears to show only UI and layout updates (header, spacing, font) without changes to core trial details such as enrollment, locations, eligibility, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference5%

- Check76 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

- Check90 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the Back to Top link was removed. No substantive content changes were detected.SummaryDifference0.3%

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.